Expert-led clinical supply strategy powered by advanced planning and analytics technologies.

NOTTINGHAM, England and LASNE, Belgium, April 27, 2026 /PRNewswire/ — Perceptive eClinical, a leading provider of interactive response technology (IRT) and eClinical solutions, and Trialzen, an expert-led Forecasting and Supply Technology company, today announced an alliance supporting Perceptive eClinical in the launch of its Clinical Intelligence Consultancy Service, Perceptive Clinical Intelligence. This transforms its long–standing clinical supply expertise into a fully integrated, expert–led service spanning the entire clinical trial lifecycle and enabled by Trialzen’s advanced clinical supply planning technologies.

Perceptive Clinical Intelligence combines Perceptive’s deep expertise in randomization and clinical supply optimization with data-driven, technology enabled mathematical optimization, simulation, and forecasting to support smarter planning across the trial lifecycle. This integrated offering helps sponsors design, stress test, and manage clinical supply strategies with greater confidence and operational control. By formalizing its in-house expertise and therapeutic experience, Perceptive unifies randomization, trial supply management technologies and clinical supply consulting to enable more informed, scalable, and lower risk supply decision making.

“Clinical trial supply decisions are too critical to rely on tools alone,” said Malcolm Morrissey, Head of Perceptive Clinical Intelligence. “While supply discussions often focus on stock levels and overage, the real risk is patient impact. Supply availability determines whether visits happen, treatment is delivered on time, and sites can operate with confidence. Effective supply management means looking beyond IP numbers to understand patient continuity and visit level risk across the entire trial.”

Industry benchmarks show that approximately 50% of Clinical Finished Goods (CFG) manufactured for clinical trials are never administered to patients, representing hundreds of millions of dollars in wasted drug supply each year1.

“Setting up Perceptive Clinical Intelligence reflects the next step in Perceptive’s evolution, combining deep clinical supply and randomization expertise with data–driven technology to enable smarter supply planning, and increased supply confidence, and continuity across the trial lifecycle,” said Shaun Hopgood, Chief Operating Officer at Perceptive eClinical.

Perceptive eClinical and Trialzen have each delivered proven results for sponsors, with real–world engagements generating savings exceeding $1 million and materially reducing supply overage.

A Technology Enabled, Expert-Led Approach

Delivered by Perceptive’s in–house specialists, the consultancy is built on 30 years of experience supporting biotech and large pharma across randomization and clinical supply management. It combines Perceptive’s proven supply–modelling expertise with Trialzen’s advanced calculation and simulation engine, fully integrated into Perceptive’s next–generation platform, Clinphone Pro.

Anchored in deep oncology expertise, where global scale, complex dosing, and multi–layered supply chains increase planning risk, the consultancy also draws on experience across Endocrinology and Metabolism, and Infectious Diseases, and supports emerging areas such as Precision and Nuclear Medicine, and Cell and Gene Therapies. 

Reflecting on this alliance and its objectives, Cedric Druck, CEO and Co–Founder of Trialzen, commented: “Trialzen was built by clinical supply experts who spent years watching planning decisions get made on spreadsheets and gut feel, then handed off to execution systems with no feedback loop. This collaboration with Perceptive closes that gap. By integrating our forecasting and simulation capabilities directly with their IRT platform, we enable sponsors to move from scenario planning to operational action in a single environment, with full transparency at every step.”

At the heart of this alliance is a shared belief that clinical supply planning and execution should live in one connected environment. “Together, Perceptive and Trialzen are working toward a unified way of operating, where strategic decisions and day–to–day execution come together, enabling greater visibility, smarter scenarios, and more confident supply decisions from manufacturing through to patient dosing”. said Tony Street, Senior Vice President Strategy at Trialzen.

Clients benefit from:

Faster study start-up and smoother amendments through early supply optimizationHigher quality supply decisions driven by expert oversight and data backed insightGreater confidence through strategic expert consultancy for complex trialsMid-study forecast adjustments and up-to-date quantitative support for key decisions

About Perceptive eClinical

Perceptive eClinical is a trusted leader in delivering advanced trial capabilities. With over 30 years of proven Interactive Response Technology (IRT) and supply management expertise, more than 500 regulatory approvals and support for three million patients worldwide, we deliver reliability, security and precision. This is reflected in our consistently high customer satisfaction score of 4.5 out of 5 over the past three years. Our future-proof IRT solution, Clinphone Pro, helps sponsors manage the speed, complexity and personalization of modern clinical trials. Built for flexibility and seamless integration, it supports smarter, more efficient studies across all phases and therapeutic areas. In 2025, Perceptive eClinical was recognized as a leader in Everest Group’s PEAK Matrix® Assessment for RTSM Solutions, affirming our commitment to innovation, global delivery excellence and measurable value for sponsors and CROs.

About Trialzen

Trialzen is a technology company built by industry experts specializing in clinical trial supply forecasting and planning. Its Forecast & Planning Solution (FPS) is a purpose-built SaaS platform that enables sponsors and CROs to model, simulate, and optimize clinical supply strategies across the full trial lifecycle. Built by clinical supply experts, Trialzen combines advanced mathematical modelling and analytics with a transparent, user-friendly interface, allowing teams to evaluate scenarios, anticipate risk, and make informed supply decisions with speed and confidence. 

Sources

McKinsey & Company, Clinical Supply Chains insights

Media Contact: Zara Broadfield, Marketing Director Perceptive eClinical, zara.broadfield@perceptive.com 

Logo – https://mma.prnewswire.com/media/2965426/Perceptive_eClinical.jpg
Logo – https://mma.prnewswire.com/media/2965427/5936695/Trialzen.jpg

View original content:https://www.prnewswire.co.uk/news-releases/perceptive-eclinical-launches-technologyenabled-clinical-supply-consultancy-in-alliance-with-trialzen-302754074.html

SHANGHAI, April 27, 2026 /PRNewswire/ — As an authorized distributor, Mouser Electronics, Inc. is focused on the rapid introduction of new products and technologies, giving customers an edge and helping speed time to market. Over 1,200 semiconductor and electronic component manufacturer brands count on Mouser to help them introduce their products into the global marketplace. Mouser’s customers can expect 100% certified, genuine products that are fully traceable from each manufacturer.

Last quarter, Mouser launched more than 9,000 part numbers ready for shipment. Some of the products introduced by Mouser from January through March 2026 include:

STMicroelectronics STM32C5 Arm® Cortex®-M33 Microcontrollers
The STM32C5 microcontrollers (MCUs) from STMicroelectronics are specifically designed to boost the performance of billions of tiny smart devices across factories, homes, cities, and infrastructure while meeting stringent cost, size, and power constraints. Based on ST’s proprietary 40 nm manufacturing process, the STM32C5 MCUs can run tasks noticeably faster than many entry-level chips currently in use. This gives products more room to include features such as improved sensing, smoother control, and enhanced user experiences while keeping dynamic power consumption low. The MCUs also integrate security features that help safeguard products against tampering and cyber risks.EDATEC ED-CM0NANO Single-Board Computer
The ED-CM0NANO is a single-board computer (SBC) from EDATEC, based on the Raspberry Pi Compute Module Zero (CM0). The ED-CM0NANO features a quad-core Arm Cortex-A53 processor running at up to 1 GHz, a Broadcom VideoCore-IV graphics processor, and a wide range of connectivity options. Optional Wi-Fi® support with an external antenna enables wireless connectivity, while integrated real-time clock (RTC) and watchdog timer enhance system reliability. These features make the ED-CM0NANO ideal for industrial control systems and Internet of Things (IoT) applications.Sensata Technologies MGD Resonix™ Refrigerant Leak Sensor
The MGD Resonix™ sensor from Sensata delivers high accuracy and fast response times in a compact module that fits into the smallest heating, ventilation, air conditioning (HVAC), and refrigeration equipment. The MGD series offers superior resistance to overexposure and poisoning, as well as to high temperatures (working temperatures up to 105 °C) and humidity. These devices also have a service life of more than 15 years with no need for calibration, making them the ideal leak-detection component for A2L HVAC and refrigeration systems.u-blox ANN-MB3 Triple-Band GNSS Antenna
The ANN-MB3 from u-blox is a best-in-class L1/L2/L5 triple-band RTK real-time kinematic (RTK) solution ideal for the F20 high-precision GNSS. Optimized for seamless integration, the ANN-MB3 antenna delivers exceptional performance with a robust design. The antenna’s compact (62 × 80 × 25.5 mm) form factor and flexible installation options enable the adoption of high-precision positioning technologies across industrial, automotive, and robotics applications.

To see more of the New Product Insider highlights, go to https://info.mouser.com/new_products/.

For more Mouser news and our latest new product introductions, visit https://www.mouser.com/newsroom/.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/mouser-electronics-new-product-insider-over-9-000-new-parts-added-in-first-quarter-of-2026–302754079.html

SOURCE Mouser Electronics

Initial listing now trading on MEXC with no prior private sale or pre-market distribution; deposits open today, and withdrawals available from April 28

DUBAI, UAE, April 27, 2026 /PRNewswire/ — XRP Healthcare, the first AI healthcare platform built on the XRP Ledger, today confirms that $XRPHAI is now live for trading on MEXC, marking the initial listing of the token and the first time it has been made available to the public.

There has been no prior private sale, no airdrop allocation, and no previous exchange or decentralised listing. This approach establishes a transparent market entry, enabling organic price discovery based on open market participation from the outset.

Deposits for $XRPHAI are open today, with withdrawals scheduled to begin on April 28, 2026.

Trading is available here:
https://www.mexc.com/exchange/XRPHAI_USDT

$XRPHAI functions as the utility token powering rewards within the XRPH AI ecosystem, enabling users to earn through Proof of Health™, a proprietary system designed to deliver Rewards for Healthy Actions through verified engagement.

Through the XRPH AI App, users interact with AI-driven healthcare tools and services, with in-app activities rewarded in $XRPHAI. These include AI-guided health interactions, wellness engagement through CalmXRPH™, image-based assessments, educational participation, multilingual support, and access to local doctor search and connection features.

The XRP Healthcare Prescription Savings Card is integrated within the XRPH AI App, free to use, and enables users to access discounted medications while earning $XRPHAI rewards for usage. The card is accepted across more than 68,000 pharmacies in the United States, including Walmart, Walgreens, and CVS Pharmacy, offering savings of up to 80% on prescriptions.

The XRP Healthcare ecosystem operates as a connected framework:

XRPH serves as the foundational token layer
$XRPHAI powers engagement and reward distribution within the XRPH AI App

Phase 1 of the XRP Healthcare rewards system is scheduled to go live on April 28, enabling users to begin earning $XRPHAI through in-app participation. Phase 2, which introduces enhanced reward functionality for XRPH holders, has already been developed and is expected to activate shortly thereafter, further linking long-term participation with increased earning potential.

$XRPHAI has a fixed maximum supply of 1,000,000,000 tokens, with an initial portion allocated to circulating liquidity. The issuing account has been permanently disabled (“blackholed”), ensuring that no additional tokens can be minted and reinforcing a finite supply model.

Further details, including full tokenomics and allocation structure, are available in the official whitepaper:
https://www.xrphealthcare.ai/docs/xrphai-whitepaper.pdf

Global healthcare expenditure is estimated at approximately $10 trillion, while the digital health sector is projected to grow into a market worth several hundred billion dollars over the coming years, driven by increasing adoption of mobile and AI-powered healthcare solutions.

Smartphone adoption has surpassed 6.8 billion users worldwide and continues to expand, particularly across emerging markets where access to traditional healthcare services remains limited. This shift toward mobile-first access enables individuals to engage with AI-driven healthcare support, connect with local providers, and participate in reward-based systems that incentivise healthier outcomes.

XRP Healthcare continues to expand its AI-driven healthcare ecosystem, Built For What‘s Next™, and is engaging with select strategic partners aligned with its roadmap, with further details available within the official whitepaper.

The initial listing on MEXC provides immediate global access to $XRPHAI, with the platform serving over 40 million users across more than 170 countries.

Following this initial listing, XRP Healthcare intends to pursue additional listings on higher-tier exchanges throughout 2026, supporting increased liquidity, broader access, and continued ecosystem growth.

Kain Roomes, Founder and CEO of XRP Healthcare, said:

“We are now live, and this marks an important milestone as we bring the XRP Healthcare ecosystem into the public market. This initial listing ensures a transparent entry point aligned with our long-term vision.”

Laban Roomes, Co-Founder and Chief Operating Officer of XRP Healthcare, added:

“Proof Of Health™ introduces a structured way to reward real participation within healthcare. With $XRPHAI now live, we are connecting engagement, technology, and incentives in a way that is Built For What‘s Next.”

About XRP Healthcare

XRP Healthcare is the first AI healthcare platform built on the XRP Ledger, combining artificial intelligence, digital health infrastructure, and blockchain interoperability to expand global access to healthcare services.

Through its XRPH AI platform, the company is developing a scalable model that connects digital engagement with real-world healthcare delivery, enabling rewards for healthy actions through verified participation.

Media Contact
Sarah James
info@xrphealthcare.com

Video – https://www.youtube.com/watch?v=rzpJoxbP8_0
Image – https://mma.prnewswire.com/media/2965884/XRP_Healthcare.jpg
Logo – https://mma.prnewswire.com/media/2365357/5937695/XRP_Healthcare_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/xrp-healthcare-xrphai-now-live-on-mexc-a-utility-token-rewarding-healthy-actions-built-on-the-xrp-ledger-302753749.html

SOURCE XRP HEALTHCARE